US Stock MarketDetailed Quotes

MIRM Mirum Pharmaceuticals

Watchlist
  • 46.390
  • -0.670-1.42%
Trading Mar 26 13:52 ET
2.27BMarket Cap-25.08P/E (TTM)

About Mirum Pharmaceuticals Company

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Company Profile

SymbolMIRM
Company NameMirum Pharmaceuticals
Listing DateJul 18, 2019
Issue Price15.00
Founded2018
CEOMr. Christopher Peetz
MarketNASDAQ
Employees322
Fiscal Year Ends12-31
Address989 East Hillsdale Boulevard,Suite 300
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-667-4085
Websitehttp://www.mirumpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Christopher Peetz
  • Director and Chief Executive Officer
  • 6.45M
  • Eric H. Bjerkholt
  • Chief Financial Officer
  • 4.34M
  • Dr. Joanne Quan, M.D.
  • Chief Medical Officer
  • --
  • Lara Longpre, PhD
  • Chief Development Officer
  • --
  • Dr. Pamela Vig, PhD
  • Chief Scientific Officer
  • --
  • Peter Radovich
  • Chief Operating Officer and President
  • 2.37M
  • Jody Howe
  • Senior Vice President, Global Controller and Principal Accounting Officer
  • --
  • Michael Grey
  • Chairman of the Board
  • 451.75K
  • Timothy P. Walbert
  • Independent Director
  • 671.53K
  • Patrick J. Heron
  • Independent Director
  • 401.75K
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • 411.75K
  • Dr. Laurent Fischer, M.D.
  • Independent Director
  • 421.75K
  • Laura A. Brege
  • Independent Director
  • 426.75K
  • Dr. Lon Cardon, PhD
  • Independent Director
  • 194.47K
  • William Carl Fairey, Jr
  • Independent Director
  • 411.75K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Ecopetrol
EC
10.395
Petroleo Brasileiro SA Petrobras
PBR
14.350
KB Home
KBH
58.770
4
Vale SA
VALE
10.085
5
Taylor Morrison Home
TMHC
60.625
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025